Skip to main content
Top

International Journal of Hematology

Issue 4/2014

Including PIH Articles on Hematopoietic Stem Cell Aging and Chronic Lymphocytic Leukemia Pathogenesis

Content (17 Articles)

Images in Hematology

Mantle cell lymphoma: a great masquerader

Jonas Paludo, Prashant Kapoor, Jennifer L. Oliveira, James A. Garrity, Grzegorz S. Nowakowski

Images in Hematology

Disseminated histoplasmosis in a renal transplant patient

Abhisek Swaika, Sikander Ailawadhi, David M. Menke

Progress in Hematology

Aging of the hematopoietic stem cells niche

Ayako Nakamura-Ishizu, Toshio Suda

Progress in Hematology

Epigenetics of hematopoietic stem cell aging and disease

Motohiko Oshima, Atsushi Iwama

Progress in Hematology

Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis

Yoshikane Kikushige, Toshihiro Miyamoto

Rapid Communication

Induction of immune tolerance to platelet antigen by short-term thrombopoietin treatment in a mouse model of immune thrombocytopenia

Tetsuya Nishimoto, Miku Numajiri, Hisataka Nakazaki, Yuka Okazaki, Masataka Kuwana

Original Article

Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency

Yushi Chikasawa, Keiko Shinozawa, Kagehiro Amano, Kyoichi Ogata, Takeshi Hagiwara, Takashi Suzuki, Hiroshi Inaba, Katsuyuki Fukutake

Original Article

Phase III, single-arm study investigating the efficacy, safety, and tolerability of anagrelide as a second-line treatment in high-risk Japanese patients with essential thrombocythemia

Yuzuru Kanakura, Yoshitaka Miyakawa, Paul Wilde, Jonathan Smith, Heinrich Achenbach, Shinichiro Okamoto

Original Article

Expressional changes of genes and miRNA in common megakaryocyte-erythroid progenitors from lower-risk myelodysplastic syndrome

Kazuhiro Maki, Ko Sasaki, Yasunobu Nagata, Fusako Nagasawa, Yuka Nakamura, Seishi Ogawa, Kinuko Mitani

Original Article

Rituximab plus a CHOP-like regimen, central nervous system prophylaxis, and contralateral testicular irradiation for localized primary testicular diffuse large B-cell lymphoma lead to prolonged progression-free survival

Kunimoto Ichikawa, Masaaki Noguchi, Michiaki Koike, Nanae Aritaka, Yasunobu Sekiguchi, Yoshitaka Sunami, Miyuki Tsutsui, Masaru Hosone, Takao Hirano, Akihiko Gotoh, Norio Komatsu

Original Article

The European Treatment and Outcome Study score is associated with clinical outcomes and treatment response following European LeukemiaNet 2013 recommendations in chronic-phase chronic myeloid leukemia

Noriyoshi Iriyama, Yoshihiro Hatta, Sumiko Kobayashi, Yoshihito Uchino, Katsuhiro Miura, Daisuke Kurita, Hitomi Kodaira, Mitsuru Inoue, Masami Takei

Original Article

Factors associated with effects of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory low-grade B cell non-Hodgkin lymphoma: single-institution experience with 94 Japanese patients in rituximab era

Naokuni Uike, Ilseung Choi, Mariko Tsuda, Shojirou Haji, Kousuke Toyoda, Youko Suehiro, Yasunobu Abe, Toshinobu Hayashi, Hirofumi Sawamoto, Koichiro Kaneko, Mototsugu Shimokawa, Makoto Nakagawa

Case Report

Phosphoglycerate kinase deficiency due to a novel mutation (c. 1180A>G) manifesting as chronic hemolytic anemia in a Japanese boy

Masato Tamai, Takeshi Kawano, Ryota Saito, Ken Sakurai, Yoshihiro Saito, Hisashi Yamada, Hiroyuki Ida, Masaharu Akiyama

Case Report

A case of neonatal alloimmune thrombocytopenia in the presence of both anti-HPA-4b and anti-HPA-5b antibody: clinical and serological analysis of the subsequent pregnancy

Tomoko Kiyokawa, Yangsook Koh, Kazuya Mimura, Kotarosumitomo Nakayama, Mika Hosokawa, Mikiko Sakuragi, Tamayo Morikawa, Mayumi Nakao, Hiroshi Aochi, Yasuo Fukumori, Takeshi Kanagawa, Keisuke Nagamine, Tadashi Kimura, Yoshiaki Tomiyama

Case Report

A possible familial lymphoproliferative disorder in two male siblings of children with recurrent wheezing and lung infections since infancy

Shih-Hsiang Chen, Shao-Hsuan Hsia, Jainn-Jim Lin, Kin-Sun Wong, Chih-Wei Wang, Lee-Yung Shih, Wen-I Lee

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine